TURRA, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 2.499
AS - Asia 1.294
EU - Europa 1.115
SA - Sud America 196
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 30
OC - Oceania 4
Totale 5.212
Nazione #
US - Stati Uniti d'America 2.435
SG - Singapore 566
CN - Cina 347
IT - Italia 251
DE - Germania 229
BR - Brasile 154
UA - Ucraina 122
FI - Finlandia 118
HK - Hong Kong 95
VN - Vietnam 87
FR - Francia 79
GB - Regno Unito 70
RU - Federazione Russa 60
IN - India 51
TR - Turchia 48
SE - Svezia 38
IE - Irlanda 37
CA - Canada 35
BD - Bangladesh 27
CZ - Repubblica Ceca 22
IQ - Iraq 17
MX - Messico 16
NL - Olanda 16
BE - Belgio 15
JP - Giappone 15
PL - Polonia 14
ZA - Sudafrica 13
AR - Argentina 12
ES - Italia 12
AT - Austria 6
CO - Colombia 6
VE - Venezuela 6
AZ - Azerbaigian 5
ET - Etiopia 5
GR - Grecia 5
IL - Israele 5
AU - Australia 4
JO - Giordania 4
PH - Filippine 4
PY - Paraguay 4
UY - Uruguay 4
UZ - Uzbekistan 4
EC - Ecuador 3
EG - Egitto 3
ID - Indonesia 3
JM - Giamaica 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KR - Corea 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
IR - Iran 1
KE - Kenya 1
LK - Sri Lanka 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TN - Tunisia 1
Totale 5.138
Città #
Singapore 299
Ashburn 281
San Jose 198
Fairfield 171
Chandler 138
New York 132
Woodbridge 109
Beijing 101
Hong Kong 94
Jacksonville 88
Helsinki 86
Houston 80
Ann Arbor 77
Seattle 77
Wilmington 76
Los Angeles 71
Munich 71
The Dalles 62
Princeton 61
Cambridge 56
Dallas 53
Brescia 47
Des Moines 41
Dublin 37
Lauterbourg 36
Istanbul 30
Shanghai 28
Boardman 27
San Francisco 26
Turku 26
Santa Clara 23
São Paulo 22
Chicago 21
Hanoi 21
Council Bluffs 19
Milan 19
Brno 18
Ho Chi Minh City 18
Brussels 15
Buffalo 15
Moscow 15
Rome 15
Denver 14
Brooklyn 13
Columbus 13
Montreal 13
Pune 13
Tokyo 13
Warsaw 13
Toronto 12
Charlotte 11
London 11
Nanchang 11
Orem 11
Redondo Beach 11
Nanjing 10
Barlassina 9
Boston 9
Jinan 9
Johannesburg 9
Amsterdam 8
Chennai 8
Da Nang 8
Phoenix 8
Stockholm 8
Bosio 7
Dearborn 7
Manchester 7
Nuremberg 7
San Diego 7
Atlanta 6
Baghdad 6
Frankfurt am Main 6
Mexico City 6
Mumbai 6
Paris 6
Poplar 6
Shenyang 6
Tianjin 6
Falkenstein 5
Haiphong 5
Hebei 5
Kocaeli 5
Amman 4
Athens 4
Baku 4
Belo Horizonte 4
Bergamo 4
Changsha 4
Cremona 4
Montevideo 4
New Delhi 4
Nürnberg 4
Tashkent 4
Vienna 4
Addis Ababa 3
Ankara 3
Augusta 3
Bari 3
Basingstoke 3
Totale 3.317
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 210
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 199
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 194
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 188
Advances in CMV Management: A Single Center Real-Life Experience 177
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 172
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 171
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 170
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 170
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 166
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 159
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 155
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 148
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 146
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 144
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 140
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 138
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 137
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 133
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 132
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 132
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 132
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 131
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 130
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 128
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 128
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 126
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 123
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 120
EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS. 118
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 113
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 111
Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis 105
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 105
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 98
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 88
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 75
Totale 5.212
Categoria #
all - tutte 27.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022300 0 22 4 29 16 28 18 25 12 57 22 67
2022/2023393 46 12 18 41 40 85 2 44 50 13 18 24
2023/2024463 33 8 50 27 20 127 16 21 65 4 6 86
2024/2025961 18 35 5 123 92 67 45 48 174 59 162 133
2025/20261.891 176 171 111 276 211 154 335 67 108 178 72 32
2026/202740 20 20 0 0 0 0 0 0 0 0 0 0
Totale 5.212